We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
451
Ultragenyx Pharmaceutical
RARE
$2.46B
$1.76M 0.01%
49,480
– –
TTEK icon
452
Tetra Tech
TTEK
$8.77B
$1.74M 0.01%
1,364,850
+109,080
+9% +$3.55M
NDAQ icon
453
Nasdaq
NDAQ
$53.4B
$1.74M 0.01%
35,747
-1,456
-4% -$73.8K
KFY icon
454
Korn Ferry
KFY
$4.31B
$1.71M 0.01%
36,075
-50,461
-58% -$2.56M
ALB icon
455
Albemarle
ALB
$13.4B
$1.71M 0.01%
10,044
-65,199
-87% -$13M
EWTX icon
456
Edgewise Therapeutics
EWTX
$4.28B
$1.71M 0.01%
298,000
– –
FDS icon
457
Factset
FDS
$10B
$1.67M 0.01%
3,817
-234
-6% -$99.7K
TTD icon
458
Trade Desk
TTD
$8.97B
$1.67M 0.01%
21,322
-175
-0.8% -$14.1K
CBOE icon
459
Cboe Global Markets
CBOE
$32.2B
$1.65M 0.01%
10,545
-1,652
-14% -$243K
NTRS icon
460
Northern Trust
NTRS
$21.8B
$1.64M 0.01%
23,672
-1,210
-5% -$91.4K
O icon
461
Realty Income
O
$61.1B
$1.63M 0.01%
32,595
– –
CPRT icon
462
Copart
CPRT
$28.5B
$1.62M 0.01%
37,648
-2,346
-6% -$104K
NTLA icon
463
Intellia Therapeutics
NTLA
$1.51B
$1.62M 0.01%
51,275
-40,000
-44% -$1.55M
CDW icon
464
CDW
CDW
$18.9B
$1.59M 0.01%
7,857
-4
-0.1% -$797
WAB icon
465
Wabtec
WAB
$49.3B
$1.57M 0.01%
146,446
+4,259
+3% +$474K
SNA icon
466
Snap-on
SNA
$21.5B
$1.57M 0.01%
6,153
-776
-11% -$210K
CHRW icon
467
C.H. Robinson
CHRW
$20.5B
$1.56M 0.01%
18,159
– –
ARKF icon
468
ARK Blockchain & Fintech Innovation ETF
ARKF
$731M
$1.56M 0.01%
80,552
– –
WST icon
469
West Pharmaceutical
WST
$23.7B
$1.55M 0.01%
4,151
– –
KPTI icon
470
Karyopharm Therapeutics
KPTI
$155M
$1.53M 0.01%
76,046
-19,667
-21% -$441K
HBAN icon
471
Huntington Bancshares
HBAN
$34B
$1.53M 0.01%
146,941
+9,557
+7% +$107K
MAS icon
472
Masco
MAS
$14.3B
$1.52M 0.01%
28,521
– –
LPLA icon
473
LPL Financial
LPLA
$27B
$1.51M 0.01%
6,346
-29,475
-82% -$6.84M
TEAM icon
474
Atlassian
TEAM
$26.5B
$1.49M 0.01%
7,372
+95
+1% +$18K
ARE icon
475
Alexandria Real Estate Equities
ARE
$9.37B
$1.48M 0.01%
14,778
+1,465
+11% +$170K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.